Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy

Numerous patients with muscle-invasive bladder cancer develop low responsiveness to cisplatin. Our purpose was to explore differential metabolites derived from serum in bladder cancer patients treated with neoadjuvant chemotherapy (NAC). Data of patients diagnosed with cT2-4aNxM0 was collected. Bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Juntao, Yang, Xiao, Zheng, Qi, Li, Kai, Cai, Lingkai, Yu, Hao, Lv, Jiancheng, Bai, Kexin, Cao, Qiang, Li, Pengchao, Yang, Haiwei, Wang, Junsong, Lu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229374/
https://www.ncbi.nlm.nih.gov/pubmed/35736490
http://dx.doi.org/10.3390/metabo12060558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229374/
https://www.ncbi.nlm.nih.gov/pubmed/35736490
http://dx.doi.org/10.3390/metabo12060558

Ejemplares similares